Abstract:Motivation: Genome and transcriptome analyses can be used to explore cancers comprehensively, and it is increasingly common to have multiple omics data measured from each individual. Furthermore, there are rich functional data such as predicted impact of mutations on protein coding and gene/protein networks. However, integration of the complex information across the different omics and functional data is still challenging. Clinical validation, particularly based on patient outcomes such as survival, is important for assessing the relevance of the integrated information and for comparing different procedures. Results: An analysis pipeline is built for integrating genomic and transcriptomic alterations from whole-exome and RNA sequence data and functional data from protein function prediction and gene interaction networks. The method accumulates evidence for the functional implications of mutated potential driver genes found within and across patients. A driver-gene score (DGscore) is developed to capture the cumulative effect of such genes. To contribute to the score, a gene has to be frequently mutated, with high or moderate mutational impact at protein level, exhibiting an extreme expression and functionally linked to many differentially expressed neighbors in the functional gene network. The pipeline is applied to 60 matched tumor and normal samples of the same patient from The Cancer Genome Atlas breast-cancer project. In clinical validation, patients with high DGscores have worse survival than those with low scores (P = 0.001). Furthermore, the DGscore outperforms the established expression-based signatures MammaPrint and PAM50 in predicting patient survival. In conclusion, integration of mutation, expression and functional data allows identification of clinically relevant potential driver genes in cancer.

Integrative analysis of dysfunctional modules driven by genomic alterations at system level across 11 cancer types.

Cancer Core Modules Identification Through Genomic and Transcriptomic Changes Correlation Detection at Network Level.

Identification of Cancer Driver Modules by Combining Network Functional and Topology Information.

Identification of Cancer Driver Modules Based on Graph Clustering from Multiomics Data

Identifying Cancer Specific Driver Modules Using A Network-Based Method

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.

Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network

The Detection of Gene Modules with Overlapping Characteristic via Integrating Multi-omics Data in Six Cancers

Integrative Computational Framework, Dyscovr, Links Mutated Driver Genes to Expression Dysregulation Across 19 Cancer Types

Detection of Driver Modules with Rarely Mutated Genes in Cancers

The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.

Identifying Cancer Driver Lncrnas Bridged by Functional Effectors Through Integrating Multi-omics Data in Human Cancers

Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis

Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer

Identifying potential cancer driver genes by genomic data integration

Identification of Ovarian Cancer Subtype-Specific Network Modules and Candidate Drivers Through an Integrative Genomics Approach.

Cooperative Driver Module Identification Based on Single Cell Data

Evaluation and Integration of Cancer Gene Classifiers: Identification and Ranking of Plausible Drivers

Identification of cancer prognosis-associated functional modules using differential co-expression networks.

Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.